Characterisation of intact recombinant human erythropoietins applied in doping by means of planar gel electrophoretic techniques and matrix-assisted laser desorption/ionisation linear time-of-flight mass spectrometry

被引:49
作者
Stübiger, G
Marchetti, M
Nagano, M
Reichel, C
Gmeiner, G
Allmaier, G
机构
[1] Vienna Univ Technol, Inst Chem Technol & Analyt, A-1060 Vienna, Austria
[2] ARC Seibersdorf Res, Doping Control Lab, A-2444 Seibersdorf, Austria
关键词
D O I
10.1002/rcm.1830
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Our experiments show that it is possible to detect different types of recombinant human erythropoietins (rhEPOs), EPO-alpha(, EPO-beta and novel erythropoesis stimulating protein (NESP), based on exact molecular weight (MW) determination by matrix-assisted laser desorption/ionisation mass spectrometry (MALDI-MS) applying a high-resolution time-of-flight (TOF) mass analyser in the linear mode. Detection limits for the highly purified, intact glycoproteins were achievable in the low fmol range (25-50 fmol) using a sample preparation method applying a hydrophobic sample support (DropStop(R)) as MALDI target surface. These results are very promising for the development of highly sensitive detection methods for a direct identification of rhEPO after enrichment from human body fluids. During our investigation we were able to differentiate EPO-alpha, EPO-beta and NESP based on distinct molecular substructures at the protein level by specific enzymatic reactions. MW determination of the intact molecules by high resolving one-dimensional sodium dodecyl sulfate /polyacrylamide gel electrophoresis (1D SDS-PAGE) and isoform, separation by planar isoelectric focusing IEF) was compared with MALDI-MS data. Migration differences between the rhEPOs were observed from gel electrophoresis, whereby MWs of 38 kDa in the case of EPO-alpha/beta and 49 kDa for NESP could be estimated. In contrast, an exact MW determination by MALDI-MS based on internal calibration revealed average MWs of 29.8 +/- 0.3 kDa for EPO-alpha/beta and 36.8 +/- 0.4 kDa for NESP. IEF separation of the intact rhEPOs revealed the presence of four to eight distinct isoforms in EPO-alpha and EPO-beta, while four isoforms, which appeared in the more acidic area of the gels, were detected by immunostaining in NESP. A direct detection of the different N- or O-glycoform pattern from rhEPOs using MALDI-MS was possible by de-sialylation of the glycan structures and after cle-N-glycosylation of the intact molecules. Thereby, the main glycoforms of EPO-alpha, EPO-beta and NESP could be characterised based on their N-glycan composition. A microheterogeneity of the molecules based on the degree of sialylation of the O-glycan was observable directly from the de-N-glycosylated protein. Copyright (C) 2005 John Wiley Sons, Ltd.
引用
收藏
页码:728 / 742
页数:15
相关论文
共 75 条
[1]   Mass spectrometry-based proteomics [J].
Aebersold, R ;
Mann, M .
NATURE, 2003, 422 (6928) :198-207
[2]  
Bahr U, 1997, J MASS SPECTROM, V32, P1111, DOI 10.1002/(SICI)1096-9888(199711)32:10<1111::AID-JMS567>3.0.CO
[3]  
2-Y
[4]   Molecular mass determination of plasma-derived glycoproteins by ultraviolet matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with internal calibration [J].
Belgacem, O ;
Buchacher, A ;
Pock, K ;
Josic, D ;
Sutton, C ;
Rizzi, A ;
Allmaier, G .
JOURNAL OF MASS SPECTROMETRY, 2002, 37 (11) :1118-1130
[5]  
Botting CH, 2000, RAPID COMMUN MASS SP, V14, P2030
[6]   Detection of recombinant human erythropoietin in urine by isoelectric focusing [J].
Breidbach, A ;
Catlin, DH ;
Green, GA ;
Tregub, I ;
Truong, H ;
Gorzek, J .
CLINICAL CHEMISTRY, 2003, 49 (06) :901-907
[7]  
Catlin DH, 2003, MIL DRUG TH, P205
[8]  
Catlin DH, 2002, CLIN CHEM, V48, P2057
[9]  
CHEN FTA, 1997, HDB CAPILLARY ELECTR, P198
[10]   Influence of matrix solution conditions on the MALDI-MS analysis of peptides and proteins [J].
Cohen, SL ;
Chait, BT .
ANALYTICAL CHEMISTRY, 1996, 68 (01) :31-37